SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10Q/A
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 31, 1995
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ____________
Commission File Number 0-12459
Biosynergy, Inc.
-----------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Illinois 36-2880990
- ----------------------------- ---------------------------
(State or other jurisdiction of (I.R.S. Employer incorporation or
organization) Identification No.)
1940 East Devon Avenue, Elk Grove Village, Illinois 60007
- -----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (708) 956-0471
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to
such filingrequirements for the past 90 days.
Yes X No
------- -------
Number of shares outstanding of common stock as of the close
of the period covered by this report: 13,806,511
Page 1 of the 7 pages contained in the sequential
numbering system.
<PAGE>
PART II - OTHER INFORMATION
---------------------------
Item 6. Exhibits and Reports on Form 8K.
--------------------------------
(a) The following exhibits are filed as a part of
this report:
(3) Articles of Incorporation and By-laws (i)
(10) Material Contracts
(a) Deferred Compensation Option Agreement, dated
January 31, 1990, between the Company and Fred K. Suzuki(ii)
(b) Stock Option Agreement, dated August 1, 1993,
between the Company and Fred K. Suzuki (iii)
(c) Promissory Note dated March 2, 1993, in the
amount of $12,100 payable to Fred K. Suzuki. (iii)
(d) Promissory Note dated July 1, 1993, in
the amount of $7,587.75 payable to Fred K. Suzuki. (iii)
(15) Letter dated September 8, 1995, regarding
interim financial information. (iv)
(27) Financial Data Schedule, attached hereto as
Exhibit 27.
(b) No Current Reports on Form 8K were filed
during the period covered by this Report.
-----------------------
[FN]
(i) Incorporated by reference to a RegistrationStatement filed on
Form S-18 with the Securities and ExchangeCommission, 1933 Act Registration
Number 2-38015C, under the Securities Act of 1933, as amended, and
Incorporated by reference, with regard to Amended By-Laws, to the
Company's Annual Report on Form 10K for fiscal year ending April 30,
1986 filed with the Securities and Exchange Commission.
(ii) Incorporated by reference to the Company's
Annual Report on Form 10K for fiscal year ending April 30, 1990
filed with the Securities and Exchange Commission.
(iv) This exhibit is included in Form 10Q for the
three month period ending July 31, 1995 as a part of the
Financial Statements, and is incorporated by reference herein.
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
Biosynergy, Inc.
Date _____________________ /s/ FRED K. SUZUKI /s/
------------------------------
Fred K. Suzuki
President, Chairman of the
Board, Chief Accounting
Officer and Treasurer
Date ______________________ /s/ LAUANE C. ADDIS /s/
-----------------------------
Lauane C. Addis
Secretary, Corporate Counsel
and Director
<PAGE>
EXHIBIT INDEX
-------------
Page Number
Pursuant to
Sequential
Exhibit Numbering
Number Exhibit System
--------- ------- -------------
27 Financial Data Schedule E-1
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
EXHIBIT 1
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED ED
IN ITS ENTIRETY BYREFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> APR-30-1996
<PERIOD-END> JUL-31-1995
<CASH> 11,414
<SECURITIES> 0
<RECEIVABLES> 61,369
<ALLOWANCES> 500
<INVENTORY> 50,883
<CURRENT-ASSETS> 127,535
<PP&E> 166,252
<DEPRECIATION> (160,613)
<TOTAL-ASSETS> 426,656
<CURRENT-LIABILITIES> 215,179
<BONDS> 0
<COMMON> 632,663
0
0
<OTHER-SE> (421,186)
<TOTAL-LIABILITY-AND-EQUITY> 426,656
<SALES> 115,873
<TOTAL-REVENUES> 116,937
<CGS> 38,275
<TOTAL-COSTS> 38,275
<OTHER-EXPENSES> 18,432
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 681
<INCOME-PRETAX> 24,202
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 24,202
<EPS-PRIMARY> .001
<EPS-DILUTED> .001
</TABLE>
